Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelomonocytic differentiation associated with NPM1-RARA rearrangement.
Yanagisawa R, Ogiso Y, Yoshikawa K, Tanaka M, Matsuda K, Ishii E. Yanagisawa R, et al. Among authors: yoshikawa k. Br J Haematol. 2017 Oct;179(2):183. doi: 10.1111/bjh.14841. Epub 2017 Jul 12. Br J Haematol. 2017. PMID: 28699672 Free article. No abstract available.
Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia.
Matsuda K, Nakazawa Y, Iwashita C, Kurata T, Hirabayashi K, Saito S, Tanaka M, Yoshikawa K, Yanagisawa R, Sakashita K, Sasaki S, Honda T, Koike K. Matsuda K, et al. Among authors: yoshikawa k. Leukemia. 2014 Jul;28(7):1545-8. doi: 10.1038/leu.2014.58. Epub 2014 Feb 5. Leukemia. 2014. PMID: 24496301 Free article. No abstract available.
Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia.
Saito S, Taira C, Matsuda K, Yanagisawa R, Morita D, Shigemura T, Yoshikawa K, Tanaka M, Sakashita K, Mukai S, Shimodaira S, Koike K, Nakazawa Y. Saito S, et al. Among authors: yoshikawa k. Leuk Lymphoma. 2020 Apr;61(4):967-970. doi: 10.1080/10428194.2019.1697813. Epub 2019 Dec 6. Leuk Lymphoma. 2020. PMID: 31809628 No abstract available.
Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
Sakashita K, Saito S, Yanagisawa R, Tanaka M, Yoshikawa K, Hirabayashi K, Tsukahara K, Motobayashi M, Nakazawa Y, Koike K. Sakashita K, et al. Among authors: yoshikawa k. Pediatr Blood Cancer. 2013 Nov;60(11):E140-2. doi: 10.1002/pbc.24622. Epub 2013 Jun 20. Pediatr Blood Cancer. 2013. PMID: 23788509 Review.
Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies.
Hirabayashi K, Nakazawa Y, Matsuura H, Hara Y, Kurata T, Hirabayashi K, Saito S, Yoshikawa K, Tanaka M, Yanagisawa R, Sakashita K, Koike K. Hirabayashi K, et al. Among authors: yoshikawa k. Int J Hematol. 2014 Apr;99(4):477-86. doi: 10.1007/s12185-014-1536-8. Epub 2014 Feb 21. Int J Hematol. 2014. PMID: 24557711
Food allergy after cord blood transplantation in children.
Sakashita K, Nakazawa Y, Yanagisawa R, Tanaka M, Saito S, Yoshikawa K, Hirabayashi K, Kusakari M, Kato S, Hidaka N, Nakayama Y, Shigemura T, Kobayashi N, Kobayashi M, Shiohara M, Koike K. Sakashita K, et al. Among authors: yoshikawa k. Br J Haematol. 2012 Sep;158(5):672-6. doi: 10.1111/j.1365-2141.2012.09204.x. Epub 2012 Jun 26. Br J Haematol. 2012. PMID: 22734509 Free article. No abstract available.
Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.
Yanagisawa R, Shimodaira S, Kojima S, Nakasone N, Ishikawa S, Momose K, Honda T, Yoshikawa K, Saito S, Tanaka M, Nakazawa Y, Sakashita K, Shiohara M, Akino M, Hirayama J, Azuma H, Koike K. Yanagisawa R, et al. Among authors: yoshikawa k. Transfusion. 2013 Sep;53(9):2053-60. doi: 10.1111/trf.12025. Epub 2012 Dec 17. Transfusion. 2013. PMID: 23252617
2,717 results